willdate
LivaNova reaches agreement to sell its heart valve business
LivaNova has entered into an agreement with investment firm Gyrus Captial whereby entities funde...
Cathy Gates named as ACC’s new CEO
Cathy Gates has been named as the new CEO of the American College of Cardiology (ACC), effective...
Cardiothoracic surgery “stifled” during COVID-19 pandemic
Reduced effectiveness of treatment and increased running costs are likely to have driven down the co...
VersaCross RF Transseptal device found to be efficient for TMVR procedures
Baylis Medical has announced the publication of data demonstrating procedural efficiency for Mit...
Scoring system stratifies “dual” risk in aortic stenosis patients
A study published in the Journal of the American College of Cardiology (JACC) has detailed a scoring...
Women face a higher risk of heart failure after STEMI
Women face a 20% increased risk of developing heart failure or dying within five years after their f...
Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor
Vectorious Medical Technologies has announced that the US Food and Drug Administration (FDA) has gra...
Philips launches IntelliSpace Portal 12 with updated cardiology imaging
Philips has announced the next generation of its advanced visualisation workspace—IntelliSpace Porta...
Gore announces encouraging early results for its pulmonary valved conduit
Gore has announced encouraging clinical results from its early feasibility study evaluating the safe...
PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure
Long-term data on the outcomes of surgery after failed transcatheter edge-to-edge mitral valve r...
PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study
Data from the EXPAND G4 study, evaluating the performance of the latest generation MitraClip (Ab...
PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement
Eight-year findings from the NOTION I trial—the first all-comers trial to randomise low-risk pat...
“Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation
Emerging data supports transcatheter techniques to treat primary mitral regurgitation, according...
PCR Valves: “Encouraging” early results from DragonFly transseptal mitral valve presented
Details of an early feasibility study of transcatheter mitral edge-to-edge repair using the Drag...
PCR Valves: Valve-in-valve replacement should be standard of care for high-risk patients
Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (22-24 November, virtu...
PCR Valves: EXPAND registry reports favourable outcomes compared to COAPT
One-year findings from the EXPAND registry, evaluating real-world use of newer-generation MitraC...
PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI
The first randomised trial comparing a course of pre-procedure percutaneous coronary interventio...
Already the gold standard? PCR Valves panellists probe accumulating TAVI evidence
Discussion during the first day of the PCR Valves e-course (22–24 November, virtual) centred on ...
Tributes paid following death of esteemed UK cardiologist Anthony Gershlick
University of Leicester and University Hospitals of Leicester NHS Trust (UHL), Leicester, UK have an...
3D-printed heart model could be used in preparation for surgical training
A study published in ACS Biomaterials Science & Engineering details the development of a 3D-prin...
Corvia completes randomisation in REDUCE LAP-HF II trial
Corvia has announced completion of randomisation in its REDUCE LAP-HF II global, pivotal trial. ...
Boston Scientific discontinues Lotus Edge TAVI device
Boston Scientific has announced a global recall of all unused inventory of its Lotus Edge transc...
AHA 2020: Sinomed announces positive safety and efficacy data from PIONEER III study
Sinomed has announced the presentation of data from its inter-continental PIONEER III study comp...
TAVI overtakes surgical aortic valve replacement in the USA
The volume of transcatheter aortic valve implantation (TAVI) procedures in the USA exceeded surg...
AHA 2020: AF detected more often in high risk patients recovering from cardiac surgery
Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recov...
AHA 2020: Patients taking statins experience similar side effects from placebos
Among patients who stopped taking statins due to side effects, researchers found the statin may ...
AHA 2020: One-month DAPT safe and feasible after stent placement
A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as effective as a longer ...
AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI
The use of ticagrelor was not superior to clopidogrel in the reduction of the rate of severe com...
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves
The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibri...
Transcatheter repair strategy for tricuspid regurgitation associated with improved outcomes
A pooled analysis of interventional studies assessing the feasibility, efficacy and clinical out...
Append Medical completes transcatheter implant-free LAA occlusion procedures
Append Medical, developer of the Appligator implant-free left atrial appendage (LAA) occlusion d...
Michael Reardon
A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michael Reardon (professor...
Higher risk in heart valve procedures performed by early-career cardiothoracic surgeons
Heart valve procedures performed by cardiothoracic surgeons with 10 years of experience or less are ...
American Heart Association issues call for action on structural racism in cardiovascular care
Structural racism is a major cause of poor health and premature death from heart disease and stroke,...
Results from Onyx One Clear study published
Results of the Onyx One Clear study, evaluating the safety and effectiveness of one-month dual a...
First 1,000 patients treated with Impella 5.5 with SmartAssist
Abiomed has announced that the first 1,000 patients have been treated with the Impella 5.5 with Smar...
England’s first COVID-19 lockdown led to a significant drop in PCI procedures
A significant decline in percutaneous coronary intervention (PCI) procedures was seen in England...
Study draws link between physician payments and device selection
Payments from device manufacturers to physicians are likely to have a bearing on device selection in...
AstraZeneca receives EU approval for heart failure drug Forxiga
AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the European Union (EU) ...
Ticagrelor may not be superior to clopidogrel in ACS patients undergoing PCI
The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing percutaneous coronar...
Recipients of MyoSeed research funding announced
MyoKardia has announced three awardees of the 2020 MyoSeeds research grant programme, who have been ...
The benefits of optical coherence tomography in the cath lab
Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coronary Intervention Pr...
Heart failure patients with COVID-19 at increased risk of death, JACC study finds
COVID-19 patients with a history of heart failure were associated with a longer duration of hospital...
Late-breaking science is alive and well despite the pandemic
Late-breaking science in interventional cardiology is alive and well despite the COVID-19 pandemic. ...
First patients treated with the Impella ECP heart pump
Abiomed has announced the treatment of the first two patients using the Impella ECP expandable percu...
Panel explores the unanswered questions around short duration DAPT
Mounting evidence over the safety and efficacy of shorter-term dual antiplatelet therapy (DAPT) ...
Foldax receives US FDA approval to expand clinical study of novel biopolymer aortic heart valve
Foldax has announced that the US Food and Drug Administration (FDA) has granted approval to expand t...
ESC events to continue digitally in 2021, society announces
The European Society of Cardiology (ESC) has announced that its full portfolio of congresses, teachi...
BioCardia shares early data from phase III CardiAMP cell therapy trial
BioCardia has announced the publication of data from the initial open-label roll-in cohort that serv...
Study assesses cardiac troponin elevation and presence of echocardiographic abnormalities in COVID-19 patients
A study published in the Journal of the American College of Cardiology (JACC) has identified differe...
US FDA approval for Abiomed’s Breethe OXY-1 system
The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clearance for an all-in-o...
Tricuspid annular dilatation predicts mortality in aortic stenosis patients undergoing TAVI
Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mortality in patients wi...
ACC publishes consensus document on TAVI-related conduction disturbances
The American College of Cardiology (ACC) has published an expert consensus decision pathway on the m...
Research programme to probe causes of unexplained cardiac arrest
A research programme into understanding the underlying causes of unexplained cardiac arrest has rece...
Meta-analysis supports use of all-cause mortality in PCI versus CABG trials
A meta-analysis of 23 randomised clinical trials comparing percutaneous coronary intervention (P...
Raising the bar for competency in high-risk coronary procedures
Rhian E Davies (University of Washington Medical Center, Seattle, USA) discusses a recent paper ...
JACC journal series looks at impact of COVID-19 on cardiovascular health
The Journal of the American College of Cardiology (JACC) has issued a three-part focus seminar on CO...
OPTIMIZE IDE study of Svelte drug-eluting stent shared at TCT Connect 2020
Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES) Integrated Delivery...
Biosensors gains CE mark approval for BioFreedom Ultra stent system
Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated coronary stent syst...
TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial
CeloNova BioSciences has announced interim results from the randomised Trial of COBRA PzF Stenti...
TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients
Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–18 October, virtual) ...
TCT Connect 2020: SOLVE-TAVI shows higher rate of stroke for balloon-expandable valve
One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rates of all-cause deat...
TCT Connect 2020: Reduced mitral regurgitation achieved with next generation MitraClip
One-year clinical outcomes from the global EXPAND study, reporting on the use of the third generatio...
Cardiovascular News 59 – October 2020: US Edition
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI
IV...
TCT Connect 2020: Disrupt CAD III meets safety and effectiveness endpoints
Shockwave Medical has announced that the coronary Investigational Device Exemption (IDE) study—Disru...
Cardiovascular News 59 – October 2020
In this issue:
POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI
IV...
TCT Connect 2020: Philips announces one-year results of DEFINE PCI
Royal Philips has announced one-year results of the DEFINE PCI study, presented at TCT Connect 2020 ...
TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (P...
TCT Connect 2020: MITHRAS trial finds interventional iASD closure non-superior to conservative therapy
Interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral v...
TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients
The REFLECT II randomised clinical trial evaluating the safety and efficacy of a cerebral embolic pr...
TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial
Findings of the SCOPE II clinical trial, which were presented during a late breaking trial sessi...
TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF
An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (14–18 October, virtu...
High-risk surgery patients vulnerable to cardiovascular diseases
One in five high-risk patients undergoing major non-cardiac surgery will develop one or more heart c...
TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system
Cardiovascular Systems has announced the presentation of results from a large retrospective obse...
TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation
Initial findings from the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NA...
Medtronic agrees to invest in TMVr device development
Medtronic has today announced a partnership with The Foundry—a medical device company incubator—to i...
TCT Connect 2020: PCI of non-flow-limiting vulnerable plaques is safe and enlarges follow-up lumen area
A pilot randomised trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable...
Medtronic announces plans for head-to-head TAVI device study
Medtronic has today announced plans to launch a randomised, head-to-head study comparing two tra...
TCT Connect 2020: NuVera announces results from first-in-human study of ICE catheter
NuVera Medical has announced positive results from its first-in-human feasibility study, assessi...
Perceval sutureless valve data presented at EACTS 2020
LivaNova has announced new data from the Perceval Sutureless Implant Versus Standard-Aortic Valve Re...
More randomised trials needed in cardiothoracic surgery, says EACTS president
The president of the European Association For Cardiothoracic Surgeons (EACTS) has called upon ca...
EACTS 2020: surgeons told to be wary of “creeping” rise of TAVI
“We now live in a world of wires,” commented Tom C Nguyen (chief of cardiac surgery, McGovern Me...
ACC announces collaboration on trial of Butterfly ultrasound system
Butterfly Network and the American College of Cardiology (ACC) have announced a collaboration on a c...
Robotics and advanced imaging provide protection and precision in PCI
This article, part of an educational supplement sponsored by Siemens Healthineers, details the use...
Development of AF after CABG linked to higher risk of cerebrovascular accidents at 10 years
Patients with postoperative atrial fibrillation (AF) after coronary artery bypass graft (CABG) s...
First patient implanted with next-generation AngelMed Guardian system
AngelMed has announced the first implant of the next-generation AngelMed Guardian system as part of ...
ESC and EACTS to review left main coronary artery stenosis evidence
The European Society of Cardiology (ESC) and the European Association for Cardiothoracic Surgery...
Assessing non-obstructive coronary disease in the cath lab: A tailored approach to treat anginal symptoms
Javier Escaned (Hospital Universitario Clínico San Carlos, Madrid, Spain) discusses the increased in...
EXCEL analysis supports protocol definition of procedural myocardial infarction
An analysis of the rates and clinical implications of alternative definitions of procedural myocardi...
Medtronic’s Resolute Onyx approved for one-month DAPT labelling by US FDA
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for ...
Study finds over 2,000 excess cardiovascular deaths in England and Wales during pandemic
Research has identified 2,085 excess deaths in England and Wales linked to cardiovascular disease du...
Cardiac Dimensions secures US$17.5 million series C financing
Cardiac Dimensions has closed a US$17.5 million series C financing round which will be used to a...
Boston Scientific launches Acurate neo2 aortic valve system in Europe
Boston Scientific has today announced it has initiated a controlled launch of the Acurate neo2 a...
InnovHeart announces first-in-human use of its Saturn mitral valve
InnovHeart has announced the successful first-in-human implantation of its proprietary Saturn transc...
Review looks at TAVI device selection and concludes head-to-head studies needed
Transcatheter aortic valve implantation (TAVI) device selection should be guided by patient, ana...
The challenges of the modern cath lab
Over the last decade, the cath lab has transformed. Interventional cardiologists are now not only tr...
V-Wave closes US$98 million financing round
V-Wave has closed a Series C financing extension of up to US$98 million, assuring capital to complet...
Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices
Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administrati...
Recurrent heart attacks declining, but overall rate remains high
After surviving a heart attack, the proportion of patients who experience a repeat attack within...
Abbott receives CE mark for the next-generation Mitraclip
Abbott has today announced it has received CE mark approval for its fourth-generation MitraClip tran...
IVUS linked to favourable PCI outcomes, but uptake is low
A study of US Medicare patients undergoing percutaneous coronary intervention (PCI) has found th...
TCT Connect 2020 to feature late-breaking interventional cardiology studies
The Cardiovascular Research Foundation (CRF) has announced that over 30 late-breaking trial and scie...
J Dawn Abbott
J Dawn Abbott is the director of interventional cardiology and an associate professor of medicine in...
Aspirin-free monotherapy after coronary artery stenting is feasible and safe
Aspirin-free prasugrel monotherapy following successful everolimus-eluting stent implantation demons...
VitalConnect begins TELESTAR-TAVR remote monitoring study
VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Te...
AHA calls for awareness of medication-induced arrhythmias
Healthcare professionals should become more familiar with medications that cause arrhythmias, ac...
Cardiac MRI effective at identifying myocarditis in athletes
Cardiac magnetic resonance imaging (MRI) is effective in identifying inflammation of the heart m...
Older patients “unaware” of heart valve disease risks
Survey results published to mark Heart Valve Disease Awareness Week show that older Europeans are un...
A variety of tools are now available for physiological assessment
Multiple studies have shown that fractional flow reserve (FFR) is a valuable modality for assessing ...
TIDES-ACS confirms performance of Hexacath’s titanium-nitride-oxide coated stent
Results of the TIDES-ACS randomised controlled trial, confirming the superior safety and sustain...
Medtronic begins early feasibility study of the Intrepid transcatheter valve system
Medtronic has announced US Food and Drug Administration (FDA) approval of an early feasibility stud...
Patient-specific, 3D printed aortic valve model used in preparation for TAVR procedure
Researchers from the University of Minnesota, with support from Medtronic, have developed a process ...
Cardiac Dimensions receives Australian regulatory approval for its Carillon mitral contour system
Cardiac Dimensions has announced that Australia’s Therapeutic Goods Administration (TGA) has approve...
Fujifilm Sonosite receives FDA clearance for COVID-19 use of its cardiac ultrasound systems
Fujifilm Sonosite has received 510(k) clearance from the US Food & Drug Administration (FDA) for...
Japan and the USA see an increase in PCI procedures
Japan and the USA have seen an increase in percutaneous coronary intervention (PCI) procedures, whic...
First patient enrolled in TRANSFORM-1 study of MagicTouch DCB
Concept Medical has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt o...
CryoLife acquires Ascyrus Medical
CryoLife has announced the acquisition of Ascyrus Medical, developer of the Ascyrus Medical Dissecti...
ACC announces revised dates for ACC.21
The American College of Cardiology (ACC) has announced that its 70th Annual Scientific Session, ACC....
BioVentrix resumes ALIVE trial after COVID-19 pause
BioVentrix has announced the resumption of cases in the pivotal ALIVE Trial studying Less Invasive V...
ESC 2020 Congress: ISCHEMIA trial suggests invasive approach benefits high risk patients
An invasive approach involving either percutaneous coronary intervention (PCI) or coronary arter...
ESC 2020 Congress: No discernible effect on saphenous vein graft patency from adding ticagrelor to aspirin after CABG
According to findings of the POPular CABG trial, the addition of ticagrelor to aspirin after cor...
Philips launches latest version of its Azurion imaging platform
Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, de...
Miracor secures financing to support PiCSO clinical study
Miracor Medical has announced the closing of a €24 million series-E round of financing. The roun...
ESC 2020 Congress: AF associated with long-term mortality in primary PCI patients regardless of LV function
Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary p...
ESC 2020 Congress: POPular TAVI findings point to aspirin-only antiplatelet strategy
The POPular TAVI trial has challenged current recommendations on antiplatelet treatment after tr...
ESC Congress 2020: Mavacamten improves heart function in HCM patients
Mavacamten (MyoKardia) improves heart function and symptoms in patients with obstructive hypertr...
ESC 2020 Congress: TMVR with Tendyne results in favourable LV remodelling
Transcatheter mitral valve replacement (TMVR) with the Tendyne device (Abbott) results in favourable...
ESC Congress 2020: Society publishes new guidelines on congenital heart disease, non-ST-segment elevation ACS
The European Society of Cardiology (ESC) has issued new guidelines, published online today in the Eu...
ESC 2020 Congress: EMPEROR-Reduced finds reduced mortality risk in HFrEF patients using empagliflozin
Empagliflozin reduces the risk of cardiovascular death or hospitalisation for heart failure in patie...
FDA approves revised labelling for Medtronic’s Evolut valve
Medtronic has announced that the US Food and Drug Administration (FDA) has approved revised comm...
Cardiovascular News 58 – August 2020
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn of long-term impact ...
Cardiovascular News 58 – August 2020: US Edition
Meta analysis puts spotlight on optimal DAPT duration
Cardiologists warn of long-term impact ...
Make confident diagnostic decisions on coronary artery diseases – fast
In this educational supplement, sponsored by Siemens Healthineers, Cardiovascular News explores ...
Philips expands cardiovascular ultrasound portfolio with Affiniti CVx
Philips announced today the latest addition to its portfolio of dedicated cardiovascular ultrasound ...
AHA issues guidance on stroke prevention in heart surgery patients
Guidelines for reducing the risk of stroke in patients undergoing heart surgery have been detail...
Heart Rhythm Society publishes Cardiovascular Digital Health Journal
The Heart Rhythm Society has announced the publication of the inaugural issue of the Cardiovascular ...
Chinese study suggests STEMI patients had increased mortality risk during COVID-19 pandemic
The risk of in-hospital death and in-hospital heart failure increased for ST-elevation myocardial in...
Heart teams and interventional cardiologists often differ over recommendations for multivessel CAD
A study comparing recommendations from a heart team versus those of an interventional cardiologi...
Women “underrepresented” in heart failure studies
Representation of women leading heart failure research remains limited, according to a...
Transcatheter tricuspid valve replacement “low risk” for complications
Transcatheter tricuspid valve replacement in the setting of trans-tricuspid pacemaker leads with...
Philips introduces Omniwire for coronary artery procedures
Royal Philips has announced the introduction of OmniWire, a solid core pressure wire for coronary ar...
ESC 2020 Congress: Digital platform takes congress to a wider audience
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 S...
Cardiovascular risk factors linked to COVID-19 complications and death
COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardi...
10-year data on VIVO ISAR drug-eluting stent published in JACC
Translumina has announced the publication of 10-year follow-up data on its dual-drug polymer-fre...
Digital learning is becoming a part of the “new normal”
With whole sections of society migrating online during the COVID-19 pandemic, e-learning has ris...
Stress may have clinical implications for heart failure patients
Mental stress and anger may have clinical implications for patients with heart failure according to ...
Biosensors announces enrolment of first patient in REFORM pivotal trial
Biosensors announced today the enrolment of the first patient in REFORM—a prospective, randomised, n...
Survey reveals patient attitudes to heart valve procedures
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with support by Medtronic, h...
InnovHeart secures US$24 million finance package
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatmen...
JAHA retracts paper calling for end to cardiology diversity programmes
The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, ...
FORWARD PRO study of Evolut Pro valve meets safety and efficacy goals
Thirty-day clinical outcomes from the FORWARD PRO international study of the Evolut Pro (Medtron...
CardioMech secures financing for mitral valve repair study
CardioMech, developer of a transfemoral, transseptally delivered mitral valve repair technology, ann...
Meta-analysis advocates “personalised approach” to DAPT duration after PCI
A meta-analysis of 24 randomised controlled trials assessing dual antiplatelet therapy (DAPT) af...
Eko and AstraZeneca announce digital cardiovascular health partnership
Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health t...
FDA issues EUA for left-sided Impella to provide left ventricular unloading
The US Food and Drug Administration (FDA) has issued an emergency use authorisation (EUA) for le...
Tailoring therapy and maximising TAVI programme efficiency
In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use...
Using remote learning to improve high-risk PCI outcomes
As interventional cardiology continues to grow with higher risk patients and more complex corona...
Frankfurt study finds high rate of cardiac complications in recovered COVID-19 patients
A German study of recently-recovered COVID-19 patients examined using magnetic resonance imaging (MR...
Japanese study finds high survival rates with use of Impella heart pump
A three-year, investigator-led, prospective study of Japanese patients who received an Impella h...
Low one-year rate of mortality found in mitral valve-in-valve replacement using Sapien 3
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (Edwards Lifesciences)...
Keystone Heart announces first case using TriGUARD 3 CEP device
Keystone Heart has announced completion of the first worldwide commercial case using the TriGUAR...
NSAIDs increase bleeding risk after myocardial infarction, Korean study finds
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart attack patients sign...
American College of Cardiology to launch JACC: Asia
The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to i...
Abiomed gains approval for data streaming from the Impella console
The US Food and Drug Administration (FDA) has approved one-way digital data streaming during pat...
TAVI or surgical valve replacement “similarly effective” in men and women
Aortic valve replacement, using either transcatheter aortic valve implantation (TAVI) or surgica...
Caption Health gains FDA approval for updates to its cardiac AI system
Caption Health, a developer of medical artificial intelligence (AI) technology, has received US ...
Mavacamten granted Breakthrough Therapy Designation
MyoKardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Ther...
Funding secured to further study of AI systems for cardiovascular health
Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small ...
Genetic testing could aid decision-making in cardiovascular healthcare
Genetic testing and counselling for inherited cardiovascular diseases may help patients and thei...
Race and gender bias may impact the timing of treatment for heart failure patients
Findings of a US investigation of clinician race and gender bias in decision-making around heart...
Inspiron sirolimus eluting stent receives CE mark approval
Scitech has announced that the Inspiron coronary sirolimus eluting stent has received CE mark approv...
Next-generation Watchman LAAC device gains US FDA approval
Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman F...
LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch
LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) cl...
LivaNova launches Perceval Plus sutureless heart valve in Europe
LivaNova has announced that the advanced Perceval Plus sutureless surgical aortic heart valve is now...
Women taking beta blockers for hypertension may have higher risk of heart failure with acute coronary syndrome
Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a n...
Fall in hospitalisations for acute coronary syndrome seen during COVID-19
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with a fall in the number...
FDA approval for Edwards Lifesciences’ KONECT RESILIA aortic valved conduit
Edwards Lifesciences has announced approval from the US Food and Drug Administration (FDA) for t...
AHA Scientific Sessions 2020 to be held virtually
The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be present...
Half of COVID-19 patients receiving echocardiograms show heart abnormalities
Around half of COVID-19 patients who received an echocardiogram in-hospital showed abnormalities in ...
FDA grants Breakthrough Device Designation for Doraya temporary catheter
Revamp Medical has announced that the US Food and Drug Administration (FDA) has granted Breakthrough...
ACIST Medical Systems announces launch of Navvus II Rapid Exchange FFR microcatheter
ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rapid Exchange FFR Micr...
Venus Medtech and Pi-Cardia to bring Leaflex catheter to Chinese market
Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex technology to China.
...
Carag Bioresorbable Septal Occluder approved for US IDE trial
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been g...
PCR e-Course 2020: Roll-in trial finds high device success rate for Amplatzer Amulet occlusion device
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high imp...
PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes vs NOACs in high risk AF patients
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, ma...
Smartphone app uses can identify lung congestion in heart failure patients
Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing ...
Philips gains FDA clearance for the use of its ultrasound portfolio to manage COVID-19 cardiac complications
Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Admi...
FDA approves update to cardiac imaging system to aid COVID-19 diagnostics
The US Food and Drug Administration (FDA) has expedited clearance of an update to software from ...
Boston Scientific announces positive PINNACLE FLX study results
Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial a...
LifeSignals receives CE mark for the ECG Remote Monitoring Patch
LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a dis...
iRhythm offers home enrolment of Zio monitoring devices
iRhythm Technologies has announced a virtual platform to support patients and clinicians in the ...
US heart societies express concern over using hydroxychloroquine and azithromycin for COVID-19
Presidents of leading cardiac organisations, including the American Heart Association (AHA), the Ame...
Webinar: Cardiovascular specialists detail COVID-19 strategies
Cardiovascular specialists from across the globe shared current knowledge and key experience of ...
AHA issues oxygenation and ventilation guidance for healthcare providers
The American Heart Association (AHA), in conjunction with the American Association for Respirato...
Athena Poppas begins ACC presidency
Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC)...
Cardiologists share COVID-19 insights
Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, i...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardi...
Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolu...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis patients
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low ris...
AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research
The American Heart Association (AHA) has committed US$2.5 million to research efforts to better unde...
Append Medical share clinical proof-of-concept results for internal sealing of LAA
Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device ...
VitalConnect adds arrhythmia detection to its remote monitoring software
VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring por...
AI-guided cardiac imaging system given FDA authorisation
The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acqu...
First patient enrolled in PREDICT-LAA clinical trial
FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA ...
ACC makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes wit...
FDA grants Breakthrough designation for ECG-based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital h...
European trial data ‘reinforce’ safety profile and efficacy of Lixiana
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial ...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary artery pressure sensor
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor Sy...
Left atrial appendage closure associated with a decreased stroke risk in AF patients
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk o...
